NEIL E. FLESHNER

Insider Reports History

Location
Indianapolis, IN
Signature
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by NEIL E. FLESHNER:

Company Role Class Num Shares Value Price $ Report Date Ownership
POINT Biopharma Global Inc. Chief Medical Officer, Director Common Stock 0 $12.45 22 Dec 2023 1510789 Ontario Inc.
POINT Biopharma Global Inc. Chief Medical Officer, Director Common Stock 0 $12.45 22 Dec 2023 Direct
POINT Biopharma Global Inc. Chief Medical Officer, Director Common Stock 0 $12.45 22 Dec 2023 Trust Controlled by Wife
POINT Biopharma Global Inc. Chief Medical Officer, Director Stock Option (Right to Buy) 0 27 Dec 2023 Direct

Insider Reports Filed by NEIL E. FLESHNER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923129772-fleshner-neil-e-2023-12-22 POINT Biopharma Global Inc. 22 Dec 2023 6 $0 4 Chief Medical Officer, Director 27 Dec 2023, 17:39
/report/000110465923113897-fleshner-neil-e-2023-10-31 POINT Biopharma Global Inc. 31 Oct 2023 1 $0 4 Chief Medical Officer, Director 02 Nov 2023, 18:30
/report/000110465923039349-fleshner-neil-e-2023-03-28 POINT Biopharma Global Inc. 28 Mar 2023 1 $0 4 Chief Medical Officer, Director 30 Mar 2023, 20:07
/report/000110465922065250-fleshner-neil-e-2022-05-25 POINT Biopharma Global Inc. 25 May 2022 1 -$4,237,172 4 Chief Medical Officer, Director 26 May 2022, 16:05
/report/000110465922041124-fleshner-neil-e-2022-03-29 POINT Biopharma Global Inc. 29 Mar 2022 1 $0 4 Chief Medical Officer, Director 31 Mar 2022, 16:57
/report/000110465921090253-fleshner-neil-e-2021-07-06 POINT Biopharma Global Inc. 06 Jul 2021 1 $0 4 Chief Medical Officer, Director 08 Jul 2021, 16:35
/report/000110465921087826-fleshner-neil-e-2021-06-30 POINT Biopharma Global Inc. 30 Jun 2021 3 $0 4 Chief Medical Officer, Director 30 Jun 2021, 21:27
/report/000110465921087808-fleshner-neil-e-2021-06-30 POINT Biopharma Global Inc. 30 Jun 2021 0 $0 3 Chief Medical Officer, Director 30 Jun 2021, 21:18